Doctors urged to discuss use of breast cancer prevention drugs

07/9/2013 | HealthDay News

The American Society of Clinical Oncology issued new practice guidelines urging physicians to discuss the use of so-called chemopreventive drugs with their female patients at high risk of breast cancer. Doctors should explain the risks and benefits of tamoxifen for high-risk premenopausal women, and those of tamoxifen, raloxifene and exemestane for high-risk postmenopausal women. The recommendations were published in the Journal of Clinical Oncology.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Actuary
Meridian Health Plan
Detroit, MI
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX